Eagle Bay Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 20.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,024 shares of the healthcare conglomerate’s stock after selling 261 shares during the quarter. Eagle Bay Advisors LLC’s holdings in UnitedHealth Group were worth $168,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Chesapeake Wealth Management raised its holdings in UnitedHealth Group by 7.0% in the 4th quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock valued at $2,647,000 after buying an additional 326 shares during the last quarter. Westhampton Capital LLC increased its position in UnitedHealth Group by 1.2% during the 1st quarter. Westhampton Capital LLC now owns 2,587 shares of the healthcare conglomerate’s stock valued at $1,223,000 after purchasing an additional 30 shares during the period. Two Sigma Investments LP acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $87,114,000. Beaumont Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $2,299,000. Finally, Alta Capital Management LLC increased its position in UnitedHealth Group by 335.1% during the 1st quarter. Alta Capital Management LLC now owns 62,712 shares of the healthcare conglomerate’s stock valued at $29,637,000 after purchasing an additional 48,300 shares during the period. Institutional investors own 92.61% of the company’s stock.
Insider Activity at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now directly owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the sale, the executive vice president now directly owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now owns 86,564 shares in the company, valued at $42,199,084.36. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,852 shares of company stock worth $4,313,962. Company insiders own 0.35% of the company’s stock.
Wall Street Analyst Weigh In
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $461.58 on Friday. The company’s 50-day moving average is $481.95 and its 200 day moving average is $488.15. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $429.74 billion, a P/E ratio of 21.11, a price-to-earnings-growth ratio of 1.35 and a beta of 0.66. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $558.10.
UnitedHealth Group (NYSE:UNH – Free Report) last issued its quarterly earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. The company had revenue of $91.93 billion for the quarter, compared to the consensus estimate of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the firm earned $5.49 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 24.85 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a $1.88 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Thursday, June 15th. UnitedHealth Group’s payout ratio is currently 34.39%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
